Shares Rise After Takeover Offer Shares in Delivery Hero rose more than 10% on Monday morning after a Financial Times report said U.S. rival Uber had considered improving its takeover bid for
Government Award Sparks Quantum Rally IBM shares rallied for a second straight day after the company received a 1 billion dollar award from the U.S. government to support its quantum computing business.
A Cautious Forecast Hits Shares Walmart shares fell about 8% on Thursday after the retailer issued a weaker-than-expected financial outlook, raising fresh questions about the health of U.S. consumers as high gas
What Happened American Airlines (AAL) shares declined Thursday morning after the airline reported record fourth-quarter revenue but issued a weak profit outlook for the first quarter. Key Earnings Highlights Analyst Perspective Bloomberg
What Happened UBS released its latest forecast for the US bond market, predicting the 10-year Treasury yield will rise to 4.25% by the end of 2025, with the 2-year note yield reaching
What Happened Netflix announced Tuesday it will raise prices on most of its subscription tiers in the US and Canada following a record-breaking 19 million new subscribers in Q4 2024. The streaming
What Happened Nvidia (NVDA) shares surged 4% on Wednesday after news broke that the company has been selected as the main technology partner for Stargate’s $500 billion AI infrastructure project. The partnership
What Happened The inauguration of Donald Trump as the 47th President of the United States on Monday was marked by the presence of the world’s wealthiest individuals, drawing comparisons to the annual
What Happened Brokerage firm Charles Schwab announced a 44% rise in profit for the fourth quarter, driven by a significant increase in asset management fees. The news sent Schwab’s shares up by
JPMorgan Chase Posts Record Earnings and Revenue, Setting Banking Milestones JPMorgan Chase reinforced its position as the largest and most profitable U.S. bank by reporting record quarterly and annual earnings and revenue
Eli Lilly Stock Falls 8% on Lower-than-Expected Zepbound Sales Forecast Eli Lilly’s shares dropped 8% on Tuesday after the pharmaceutical giant forecast fourth-quarter sales for its weight-loss drug Zepbound below Wall Street
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion Johnson & Johnson (J&J) announced on Monday its $14.6 billion acquisition of neurological drugmaker Intra-Cellular Therapies, marking its largest deal in over two
Blue Origin Scrubs First New Glenn Rocket Launch Due to Technical Issues Blue Origin canceled the much-anticipated debut launch of its massive New Glenn rocket early Monday due to technical problems. The